Mode
Text Size
Log in / Sign up

Coexisting COPD and Atrial Fibrillation are associated with increased risk of mortality and bidirectional disease associationPatients with both lung and heart conditions face higher risks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that comorbid COPD and Atrial Fibrillation are associated with increased risks for both conditions and higher mortality.

This meta-analysis synthesized 48 unique publications to evaluate the bidirectional risk between Chronic Obstructive Pulmonary Disease (COPD) and Atrial Fibrillation (AF). The analysis indicates a significant association where patients with AF had an increased risk of COPD (effect size 1.56; 95% CI 1.06–2.29), and patients with COPD showed an increased risk of AF (effect size 1.72; 95% CI 1.42–2.09).

Regarding mortality outcomes, the study found that patients with COPD and comorbid AF experienced higher risks of both short-term mortality (effect size 1.76) and long-term mortality (effect size 1.27). Similarly, patients with AF and comorbid COPD showed increased risk for short-term mortality (effect size 1.54) and long-term mortality (effect size 1.68).

The authors note that the evidence is limited by the observational nature of the included studies and substantial heterogeneity among the data. Because these findings are associations rather than causal effects, clinical application should be interpreted with caution. The results highlight the necessity for integrated management strategies for patients presenting with both COPD and AF.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the interplay between respiratory and cardiac comorbidities. While previous evidence has explored specific interventions like IoT-assisted pulmonary rehabilitation for stable COPD patients or SGLT2 inhibitors for heart failure, this study specifically quantifies the bidirectional risk and mortality implications of concurrent COPD and Atrial Fibrillation.

Living with a chronic lung condition like COPD is hard enough, but it becomes even more complex when combined with an irregular heartbeat known as atrial fibrillation. New data shows that these two conditions often go hand in hand, creating a tougher road for patients managing their health.

A review of 48 different publications found a clear link between the two. People with atrial fibrillation were more likely to have COPD, and those with COPD were more likely to develop atrial fibrillation. This connection is important because it suggests that these conditions may impact each other's progression over time.

Most importantly, the data shows that having both conditions increases the risk of death in the short and long term. While these findings are based on observational studies rather than direct cause and effect, they highlight how much more careful doctors need to be when treating patients who have both issues. Because of the variety in the original studies, these results show a strong trend but aren't a perfect rule for every individual.

What this means for you:
Patients with both COPD and atrial fibrillation face higher risks of mortality than those with only one condition.

Common questions

How does having both COPD and atrial fibrillation affect survival?

The data shows that patients with both conditions face an increased risk of mortality in both the short term and long term. Specifically, those with COPD who also have atrial fibrillation showed higher risks for death compared to others.

Is there a link between lung disease and heart rhythm issues?

Yes, the study found a bidirectional risk. This means that people with atrial fibrillation were more likely to have COPD, and those with COPD were also more likely to have atrial fibrillation.

Does having one condition cause the other?

The study shows a strong association between these two conditions, but it does not prove that one causes the other. Because the data comes from observational studies, we cannot say for certain that COPD causes atrial fibrillation or vice versa.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
ObjectiveThis study aims to comprehensively evaluate the bidirectional epidemiological association between chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF), as well as their combined impact on prognosis, providing evidence to inform the clinical management of comorbidities.MethodsIn accordance with PRISMA guidelines, a systematic literature search was conducted in PubMed, EMBASE, and the Cochrane Library from inception through June 2025, focusing on cohort and case-control studies. Study quality was assessed using the Newcastle-Ottawa Scale, and odds ratios (OR) were pooled using either random-effects or fixed-effects models to quantify the bidirectional risk between COPD and AF and their prognostic effects.ResultsA total of 48 unique publications were included. The findings showed that AF was associated with a higher risk of COPD (OR = 1.56, 95% CI 1.06–2.29), and COPD was similarly associated with a higher risk of AF (OR = 1.72, 95% CI 1.42–2.09). Additionally, AF in COPD patients was associated with increased short-term (OR = 1.76) and long-term (OR = 1.27) mortality risks, while COPD in AF patients was also associated with increased mortality risks (short-term OR = 1.54, long-term OR = 1.68).ConclusionCOPD and AF showed a bidirectional observational association, and their coexistence was associated with increased mortality risk. Given the observational nature of the included studies and substantial heterogeneity, these findings should be interpreted as associations rather than causal effects. These findings highlight the need for integrated and individualized management strategies in patients with comorbid COPD and AF.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251069785
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.